Literature DB >> 3678848

Function of the diabetic retina after panretinal argon laser coagulation.

V Seiberth1, E Alexandridis, W Feng.   

Abstract

Panretinal photocoagulation has been demonstrated to have a beneficial effect on the natural history of diabetic retinopathy. However, it is associated with detectable loss of retinal function. To determine the best coagulation technique we conducted a prospective study in 32 eyes of 16 patients. We investigated retinal function in relation to spot size and scatter density after panretinal laser coagulation. One eye was treated with approximately 400 comparatively large laser spots (0.6-0.8 mm diameter), whereas the fellow eye was coagulated with approximately 1500 small spots (0.2-0.4 mm diameter), so that the total coagulated area was almost the same in both eyes. Subjective parameters (visual acuity, perimetry, dark adaptation, photostress), as well as objective functions (electroretinogram, ERG; electro-oculogram, EOG), were studied preoperatively and then postoperatively over a time span of 6 months. Pronounced impairment of retinal function was detected, which recovered after 3 months on the average. When the pairs of eyes were compared, persistent visual field scotomas as detected by computerized static perimetry, occurred less frequently in eyes subjected to small coagulation spots, although this tendency was not statistically significant.

Entities:  

Mesh:

Year:  1987        PMID: 3678848     DOI: 10.1007/bf02334163

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1976-04       Impact factor: 5.258

2.  Dark adaptation in diabetics.

Authors:  T Amemiya
Journal:  Ophthalmologica       Date:  1977       Impact factor: 3.250

3.  Photocoagulation in diabetic retinopathy with special reference to its effect on dark adaptation.

Authors:  B Zetterström; M Gjötterberg
Journal:  Acta Ophthalmol (Copenh)       Date:  1973

4.  [Electrooculographic findings in uveitis].

Authors:  F Wehner; E Alexandridis; F Bettinger
Journal:  Ber Zusammenkunft Dtsch Ophthalmol Ges       Date:  1970

5.  Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy.

Authors:  S M Meyers
Journal:  Am J Ophthalmol       Date:  1980-08       Impact factor: 5.258

6.  Visual fields in diabetic retinopathy.

Authors:  K I Wisznia; T W Lieberman; I H Leopold
Journal:  Br J Ophthalmol       Date:  1971-03       Impact factor: 4.638

7.  Xenon arc photocoagulation of proliferative diabetic retinopathy. A review of 2688 consecutive eyes in the format of the Diabetic Retinopathy Study.

Authors:  E Okun; G P Johnston; I Boniuk; N P Arribas; R F Escoffery; M G Grand
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

8.  Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

9.  Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings.

Authors: 
Journal:  Ophthalmology       Date:  1978-01       Impact factor: 12.079

10.  The photostress recovery test in the clinical assessment of visual function.

Authors:  J S Glaser; P J Savino; K D Sumers; S A McDonald; R W Knighton
Journal:  Am J Ophthalmol       Date:  1977-02       Impact factor: 5.258

View more
  11 in total

1.  Field loss after pan retinal photocoagulation with diode and argon lasers.

Authors:  S Buckley; L Jenkins; L Benjamin
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

2.  Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation.

Authors:  D Pahor
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

3.  Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. A randomized study with blue-green argon and red krypton lasers.

Authors:  C Capoferri; M Bagini; A Chizzoli; A Pece; R Brancato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 4.  Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.

Authors:  Maxwell S Stem; Thomas W Gardner
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 5.  Laser photocoagulation for proliferative diabetic retinopathy.

Authors:  Jennifer R Evans; Manuele Michelessi; Gianni Virgili
Journal:  Cochrane Database Syst Rev       Date:  2014-11-24

6.  Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.

Authors:  Grace E Boynton; Maxwell S Stem; Leon Kwark; Gregory R Jackson; Sina Farsiu; Thomas W Gardner
Journal:  Ophthalmology       Date:  2015-01-17       Impact factor: 12.079

7.  Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation.

Authors:  V Seiberth; S Schatanek; E Alexandridis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

8.  Visual fields in patients who have undergone vitrectomy for complications of diabetic retinopathy. A prospective study.

Authors:  Allon Barsam; Alistair Laidlaw
Journal:  BMC Ophthalmol       Date:  2006-01-26       Impact factor: 2.209

Review 9.  A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders.

Authors:  Paula Scholz; Lebriz Altay; Sascha Fauser
Journal:  Adv Ther       Date:  2017-05-24       Impact factor: 3.845

Review 10.  Different lasers and techniques for proliferative diabetic retinopathy.

Authors:  Tanya Moutray; Jennifer R Evans; Noemi Lois; David J Armstrong; Tunde Peto; Augusto Azuara-Blanco
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.